Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alnylam Pharmaceuticals (NQ: ALNY )

193.90 USD +10.46 (+5.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 972,857
Open 183.80
Bid (Size) 190.00 (10)
Ask (Size) 253.58 (1)
Prev. Close 183.44
Today's Range 183.32 - 194.28
52wk Range 119.29 - 186.48
Shares Outstanding 118,847,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Alnylam Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Period Activity
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter ended June 30, 2021 and reviewed recent... 
From Business Wire News Releases
Alnylam and PeptiDream Enter into Collaboration Agreement to Discover and Develop Peptide-siRNA Conjugates for Targeted Delivery of RNAi Therapeutics to a Broader Range of Extrahepatic Tissues
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and PeptiDream, Inc. (Tokyo Stock Exchange: 4587), the leading peptide-based drug discovery company with its... 
From Business Wire News Releases

Performance

YTD
+51.37%
+51.37%
1 Month
+11.19%
+11.19%
3 Month
+46.15%
+46.15%
6 Month
+28.20%
+28.20%
1 Year
+26.93%
+26.93%

More News

Read More
Alnylam Reports Positive Topline Results from ILLUMINATE-C Phase 3 Study of Lumasiran in Patients with Advanced Primary Hyperoxaluria Type 1
From Business Wire News Releases
Alnylam to Webcast Conference Call Discussing Second Quarter 2021 Financial Results
From Business Wire News Releases
Notable Monday Option Activity: TDOC, REG, ALNY
Tags Stocks
From Market News Video
PeptiDream Inks $2.2B Deal To Broaden Alnylam's siRNA Delivery Scope
Tags ALNY General Health Care
From Benzinga
Alnylam Pharmaceuticals, inc (ALNY) Q2 2021 Earnings Call Transcript
Tags Market News ALNY
From Motley Fool
Alnylam's Lumasiran Substantially Reduces Plasma Oxalate Levels PH1 Patients With Severe Renal Impairment
Tags Market News Briefs ALNY
From Benzinga
You can beat stock market indexes — this fund manager has, and this is how she and her team did it
Tags AXP AMZN SQ
From MarketWatch
Thinking about trading options or stock in Alnylam Pharmaceuticals, Tesla, Cintas, GameStop, or Microsoft?
From PR Newswire
Noteworthy Wednesday Option Activity: Z, ALNY, SBUX
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.